Navigation Links
Medco Research Institute Study Shows Some Patients Discontinue New Anticoagulant Drug Early, Which May Increase Stroke Risk
Date:11/14/2011

ORLANDO, Fla., Nov. 14, 2011 /PRNewswire/ -- Patients using Pradaxa (dabigatran), a new blood thinner aimed at preventing stroke and blood clots, failed to remain on the treatment 17 percent of the time after the first four months, according to a study presented at the American Heart Association's Scientific Sessions.

(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO)

The research conducted by Medco Research Institute™, a subsidiary of Medco Health Solutions, Inc. (NYSE: MHS), is the first real-world study to examine dabigatran's use since its introduction last year.  Dabigatran is an alternative to the popular blood-thinner warfarin, a drug dating to the 1950s and sold under the brand names Coumadin® and Jantoven®.  Warfarin can be difficult to dose properly and patients need to be monitored closely to prevent bleeds or blood clots.  The study showed that warfarin therapy was prescribed in 71 percent of patients during the prior 6 months to starting dabigatran treatment, suggesting that prescribers are adopting dabigatran as an alternative to warfarin.

"Dabigatran is indicated to prevent serious health conditions such as stroke and systemic embolism in patients with nonvalvular atrial fibrillation, so we wanted to examine how people are using the medication, and more importantly, if patients are staying on this vital therapy," said Dr. Eric Stanek, vice president of research at Medco.  "We are seeing a sizable proportion of patients drop off treatment in a fairly short time.  This is a twice-daily drug and stroke prevention outcomes may be particularly sensitive to how consistently patients take it, pointing to a need and opportunity to provide dedicated and proactive patient support."

"We have begun to engage patients with
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nationwide Coalition Joins Reps. Courtney & Marino Outside U.S. Capitol To Oppose Express Scripts/Medco Merger
2. Lawmakers, Pharmacists Rally Against Express Scripts-Medco Merger Proposal at U.S. Capitol
3. Nationwide Coalition Issues Call To Action To Stop Express Scripts/Medco Merger
4. Nationwide Coalition Opposes Express Scripts/Medco Merger
5. Medco, Quest Diagnostics Personalized Medicine Study Yields Additional Clues about Patient Engagement
6. Medco Wins 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection
7. Merger of Express Scripts and Medco Health Solutions Will Address the Bipartisan Mandate for Safer, More Affordable, Higher Quality Healthcare
8. Polymedco, Inc., and Cardinal Health Sign Agreement for Distribution of Oncologic Diagnostic Test Kits to Acute Care Market
9. Polymedco Announces Publication in Epidemiologic Reviews
10. Prometheus and the Medco Research Institute® to Evaluate the Use of Prometheus Thiopurine Metabolite Testing for Optimizing Treatment of Inflammatory Bowel Disease Patients
11. Express Scripts and Medco Health Solutions Sign Definitive Merger Agreement; Medco Shareholders to Receive $29.1 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... In the latest call for gender equity ... than 60 doctors and leading medical experts from across ... Food and Drug Administration,s (FDA) decision to approve 26 ... sexual dysfunction compared with ZERO for women,s most common ... women by approving the first-ever drug to treat Hypoactive ...
(Date:8/1/2014)... DALLAS , August 1, 2014 ... Care Market by Type (Traditional Wound Closure, Anti infective), ... Active (Artificial Skin & Skin Substitutes), Pressure Relief ... by MarketsandMarkets, the global Wound Care Market is expected ... Billion in 2014, growing at a CAGR of ...
(Date:8/1/2014)... PLYMOUTH MEETING, Pa. , Aug. 1, 2014 /PRNewswire/ ... that it will host a conference call to report ... 11, 2014 at 9:00 AM ET. CEO Dr. ... will discuss second quarter earnings, provide a corporate ... The update will include clinical development plans for VGX-3100, ...
Breaking Medicine Technology:60+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 260+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 3Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3
... , CHANGCHUN, China and LOS ... Bulletin Board: CYXN) ("Yongxin" or,"the Company"), a leading pharmaceutical ... the third quarter ended,September 30, 2009. , ... products depend on discretionary,spending, we expect as the economy ...
... , MINNEAPOLIS, Dec. 10 Uroplasty, Inc. ... that develops, manufactures and markets innovative proprietary products to ... the OrBIT Trial of its Urgent® PC Neuromodulation System ... edition of THE JOURNAL OF UROLOGY® . The ...
Cached Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4
(Date:8/1/2014)... (PRWEB) August 01, 2014 Hot off the ... destination spa category of the World’s Best Awards by ... a month-long celebration of National Relaxation Day (technically August 15). ... series of MAJOR experts to help guests celebrate relaxation throughout ... it is for health and wellness to carve out time ...
(Date:8/1/2014)... HealthDay Reporter FRIDAY, Aug. 1, ... a time-honored destination for a good cut and conversation. ... be the spot to tackle an often overlooked health concern: ... partnership, the U.S. Centers for Disease Control and Prevention, together ... help of barbershop staff to both discuss and diagnose high ...
(Date:8/1/2014)... 2014 For years, proponents have praised ... study conducted by the Ohio State University, ... behind in terms of their health and development, raising ... best for their baby. So does this new research ... Steven Shapiro , chair of Pediatrics at Abington Memorial ...
(Date:8/1/2014)... GlobalDatas new report, "United ... provides key market data on the United ... value, in millions of US dollars, volume ... dollars) within market segments - Electrosurgical RF ... Plasma Coagulation Generators. , To view the ...
(Date:8/1/2014)... -- Women who serve in the U.S. military are ... a new study suggests. Overall, members of the ... researchers found that women respond differently to their experience ... to concerns about sexual harassment or being treated unfairly, ... sexual assault, both within and outside the military, and ...
Breaking Medicine News(10 mins):Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 2Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 3Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 4Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 2Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 3Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 2Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 3Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 2Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 3Health News:Women in Military Drink Less Than Civilians, Report Shows 2
... of the most aggressive cancers worldwide and its incidence is ... infection and aflatoxin contamination of foodstuffs. The cancer is also ... and China have been studying gene activity in liver tumors ... of detecting tumors that spread. They found that there is ...
... born during night time have a higher risk of ... day time. Previous studies have also shown that infants ... an increased risk of death at birth, urging the ... obstetric and neonatal care during the night. Researchers conducted ...
... been believed, over the years, to be a potential cure against ... true by researchers who have studied changes in immune cells' response ... 12 healthy subjects who took one gram of vitamin C a ... in all of them during the period. Their finding(in two patients) ...
... from The Forsyth Institute in Boston and the University of ... of the Journal of Microbiology that bad breath or halitosis ... back portion of the top of your tongue. The study ... the tongues of those with halitosis and those with fresh ...
... of the long-running Framingham Heart Study have now found ... levels of homocysteine, an amino acid whose build-up has ... and dementia, increases the risk of developing congestive heart ... age 72 years, who were studied during 1979 to ...
... researchers in the Journal of Hypertension indicates that ... improve their atherosclerotic risk profile by consuming alcohol ... serum lipoprotein(a), a powerful predictor of organ damage, ... studied 402 patients with untreated essential hypertension to ...
Cached Medicine News:Health News:Germs to blame for bad breath 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: